Cannabis Control Board warns against multi-year product registrations and new product classes

The Cannabis Control Board urged caution on a Senate proposal to create different product classes with varying registration durations, saying the change would impose IT and administrative costs and might reduce market safety.

Gabe Gilman told the committee the Senate made the product-duration provision permissive, which the CCB appreciates, but he warned that assigning different registration lengths would require building evaluation teams, new processes and IT changes. "State cannabis regulators like us are not equipped to play FDA," Gilman said, noting that the Food and Drug Administration has specialized scientific capacity the state does not. He added concerns about novel devices (for example vape-device wicks) that lack long-term safety data and could leach contaminants over time if not re-evaluated regularly.

CCB recommended keeping one-year product registrations to allow yearly review of new products and to avoid creating a durable bureaucracy for duration assignments; they flagged topicals as a possible exception that may warrant longer registration.